MRI May Help to Diagnose, Stage, and Treat Diabetes
By MedImaging International staff writers Posted on 26 Aug 2009 |
Noninvasive magnetic resonance imaging (MRI) may aid clinicians in the early diagnosis, staging, and treatment of diabetes.
Research performed at two Boston, MA, USA-based institutions, Massachusetts General Hospital and Harvard Medical School, is the first study of its kind to apply noninvasive imaging techniques to diabetes research.
"With noninvasive MRI we have the ability to evaluate beta cell mass, a major factor of insulin secretion that is significantly reduced in type II diabetes and almost gone in type I,” said Anna Moore, M.D., lead author of the study. "We are also able to detect inflammation of the pancreas and vascular changes associated with type I and type II diabetes. This opens a huge area that is closed right now. Knowing the number of functional beta cells left would allow physicians to develop the most appropriate treatment plans for their patients. It would also allow them to respond, change, or manipulate those treatment plans at any time.”
This study was published in the August 2009 issue of the American Journal of Roentgenology.
"Noninvasive MRI could no doubt tremendously assist in achieving insulin independence in patients with diabetes,” concluded Dr. Moore.
Related Links:
Massachusetts General Hospital
Harvard Medical School
Research performed at two Boston, MA, USA-based institutions, Massachusetts General Hospital and Harvard Medical School, is the first study of its kind to apply noninvasive imaging techniques to diabetes research.
"With noninvasive MRI we have the ability to evaluate beta cell mass, a major factor of insulin secretion that is significantly reduced in type II diabetes and almost gone in type I,” said Anna Moore, M.D., lead author of the study. "We are also able to detect inflammation of the pancreas and vascular changes associated with type I and type II diabetes. This opens a huge area that is closed right now. Knowing the number of functional beta cells left would allow physicians to develop the most appropriate treatment plans for their patients. It would also allow them to respond, change, or manipulate those treatment plans at any time.”
This study was published in the August 2009 issue of the American Journal of Roentgenology.
"Noninvasive MRI could no doubt tremendously assist in achieving insulin independence in patients with diabetes,” concluded Dr. Moore.
Related Links:
Massachusetts General Hospital
Harvard Medical School
Latest MRI News
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs
- Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy